NASDAQ:OCGN).” data-reactid=”28″>It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we’d be remiss not to mention that insider sales have been known to precede tough periods for a business. So shareholders might well want to know whether insiders have been buying or selling shares in Ocugen, Inc. (NASDAQ:OCGN).
What Is Insider Buying?
It’s quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, most countries require that the company discloses such transactions to the market.
We don’t think shareholders should simply follow insider transactions. But it is perfectly logical to keep tabs on what insiders are doing. As Peter Lynch said, ‘insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise’.
Check out our latest analysis for Ocugen ” data-reactid=”36″> Check out our latest analysis for Ocugen
Ocugen Insider Transactions Over The Last Year
The Founder Shankar Musunuri made the biggest insider purchase in the last 12 months. That single transaction was for US$108k worth of shares at a price of US$0.41 each. That implies that an insider found the current price of US$0.48 per share to be enticing. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company’s future. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today’s share price, as the discount to value may have narrowed with the rising price. In this case we’re pleased to report that the insider purchases were made at close to current prices.
In the last twelve months Ocugen insiders were buying shares, but not selling. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
list of companies. (Hint: insiders have been buying them).” data-reactid=”52″>There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).
Ocugen Insiders Bought Stock Recently
There was some insider buying at Ocugen over the last quarter. Independent Director Kirsten Castillo shelled out US$23k for shares in that time. It’s good to see the insider buying, as well as the lack of recent sellers. However, in this case the amount invested recently is quite small.
Insider Ownership of Ocugen
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. Based on our data, Ocugen insiders have about 3.4% of the stock, worth approximately US$2.2m. I generally like to see higher levels of ownership.
So What Do The Ocugen Insider Transactions Indicate?
4 warning signs for Ocugen (2 can’t be ignored!) that we believe deserve your full attention.” data-reactid=”58″>Insider purchases may have been minimal, in the last three months, but there was no selling at all. That said, the purchases were not large. On a brighter note, the transactions over the last year are encouraging. We’d like to see bigger individual holdings. However, we don’t see anything to make us think Ocugen insiders are doubting the company. So these insider transactions can help us build a thesis about the stock, but it’s also worthwhile knowing the risks facing this company. When we did our research, we found 4 warning signs for Ocugen (2 can’t be ignored!) that we believe deserve your full attention.
list of interesting companies.” data-reactid=”63″>Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
Get in touch with us directly. Alternatively, email [email protected].” data-reactid=”65″>This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.